Ilan Asher

818 total citations
37 papers, 571 citations indexed

About

Ilan Asher is a scholar working on Immunology, Rheumatology and Physiology. According to data from OpenAlex, Ilan Asher has authored 37 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 11 papers in Rheumatology and 9 papers in Physiology. Recurrent topics in Ilan Asher's work include Systemic Lupus Erythematosus Research (8 papers), T-cell and B-cell Immunology (8 papers) and Allergic Rhinitis and Sensitization (7 papers). Ilan Asher is often cited by papers focused on Systemic Lupus Erythematosus Research (8 papers), T-cell and B-cell Immunology (8 papers) and Allergic Rhinitis and Sensitization (7 papers). Ilan Asher collaborates with scholars based in Israel and United States. Ilan Asher's co-authors include Zev Sthoeger, Daniel Elbirt, Keren Mahlab‐Guri, Amir Sharabi, Heidy Zinger, Edna Mozes, Nava Chapnik, Oren Froy, Molly Dayan and Alessandro Neri and has published in prestigious journals such as PLoS ONE, The American Journal of Medicine and Medicine.

In The Last Decade

Ilan Asher

35 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilan Asher Israel 15 223 179 82 72 62 37 571
Gabriel Cohen United States 10 145 0.7× 157 0.9× 71 0.9× 34 0.5× 103 1.7× 29 600
Emõke Endreffy Hungary 16 121 0.5× 111 0.6× 18 0.2× 67 0.9× 141 2.3× 38 693
E Livni Israel 18 219 1.0× 186 1.0× 81 1.0× 131 1.8× 124 2.0× 75 1.0k
Ori Elkayam Israel 16 139 0.6× 220 1.2× 39 0.5× 39 0.5× 82 1.3× 44 735
Neil Kramer United States 14 71 0.3× 183 1.0× 20 0.2× 80 1.1× 43 0.7× 35 655
Stella Bowcock United Kingdom 13 216 1.0× 50 0.3× 37 0.5× 40 0.6× 102 1.6× 43 727
J. Keith Pinckard United States 11 158 0.7× 41 0.2× 48 0.6× 31 0.4× 109 1.8× 26 506
B. Ramsay Ireland 13 316 1.4× 105 0.6× 15 0.2× 43 0.6× 28 0.5× 44 684
Paul J. Newcombe United Kingdom 14 100 0.4× 37 0.2× 39 0.5× 73 1.0× 148 2.4× 36 684
L Hill United States 11 95 0.4× 77 0.4× 58 0.7× 95 1.3× 59 1.0× 16 541

Countries citing papers authored by Ilan Asher

Since Specialization
Citations

This map shows the geographic impact of Ilan Asher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilan Asher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilan Asher more than expected).

Fields of papers citing papers by Ilan Asher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilan Asher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilan Asher. The network helps show where Ilan Asher may publish in the future.

Co-authorship network of co-authors of Ilan Asher

This figure shows the co-authorship network connecting the top 25 collaborators of Ilan Asher. A scholar is included among the top collaborators of Ilan Asher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilan Asher. Ilan Asher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elbirt, Daniel, Keren Mahlab‐Guri, Ilan Asher, et al.. (2025). Clinical significance of very high IgE levels (≥1000 IU/mL): Population-based study of 118,211 adults. Journal of Allergy and Clinical Immunology Global. 4(2). 100403–100403. 1 indexed citations
2.
Elbirt, Daniel, Keren Mahlab‐Guri, Ilan Asher, et al.. (2025). IgE deficiency (<2.5 IU / mL ) in children: Clinical insights from a population‐based study of 123,393 subjects. Pediatric Allergy and Immunology. 36(4). e70092–e70092.
3.
Mahlab‐Guri, Keren, et al.. (2023). Modification of Allergen Subcutaneous Immunotherapy Safety Precautions and Systemic Allergic Reaction Rate Reduction. Immunotherapy. 15(16). 1389–1400. 1 indexed citations
4.
Elbirt, Daniel, Keren Mahlab‐Guri, Ilan Asher, et al.. (2023). Food‐induced anaphylaxis during infancy is associated with later sleeping and eating disorders. Pediatric Allergy and Immunology. 34(12). e14061–e14061. 2 indexed citations
5.
Asher, Ilan, et al.. (2022). Early childhood allergy linked with development of attention deficit hyperactivity disorder and autism spectrum disorder. Pediatric Allergy and Immunology. 33(6). 16 indexed citations
6.
Mahlab‐Guri, Keren, et al.. (2021). Characteristics of patients with spontaneous resolution of sesame allergy. Annals of Allergy Asthma & Immunology. 128(2). 206–212. 16 indexed citations
7.
Sthoeger, Zev, Amir Sharabi, Heidy Zinger, Ilan Asher, & Edna Mozes. (2018). Indoleamine-2,3-dioxygenase in murine and human systemic lupus erythematosus: Down-regulation by the tolerogeneic peptide hCDR1. Clinical Immunology. 197. 34–39. 3 indexed citations
8.
Sthoeger, Zev, Margalit Lorber, Elias Toubi, et al.. (2017). Anti-BLyS Treatment of 36 Israeli Systemic Lupus Erythematosus Patients.. PubMed. 19(1). 44–48. 13 indexed citations
9.
Vadasz, Zahava, Daniel Elbirt, Keren Mahlab‐Guri, et al.. (2017). Low levels of the immunoregulator Semaphorin 4D (CD100) in sera of HIV patients. Clinical Immunology. 191. 88–93. 7 indexed citations
10.
Asher, Ilan, Daniel Elbirt, Frank Maldarelli, et al.. (2016). Characteristics and Outcome of Patients Diagnosed With HIV at Older Age. Medicine. 95(1). e2327–e2327. 14 indexed citations
11.
Asher, Ilan, et al.. (2016). Idiopathic CD4 Lymphopenia: Severe CD4 Lymphopenia in the Absence of Human Immunodeficiency Virus Infection.. PubMed. 18(10). 627–629. 4 indexed citations
12.
Mahlab‐Guri, Keren, et al.. (2014). Angiotensin-converting Enzyme Inhibitor-induced Angioedema. The American Journal of Medicine. 128(2). 120–125. 74 indexed citations
13.
Sthoeger, Zev, Heidy Zinger, Amir Sharabi, Ilan Asher, & Edna Mozes. (2013). The Tolerogenic Peptide, hCDR1, Down-Regulates the Expression of Interferon-α in Murine and Human Systemic Lupus Erythematosus. PLoS ONE. 8(3). e60394–e60394. 33 indexed citations
14.
Agmon‐Levin, Nancy, et al.. (2013). [Allergy to drugs and contrast media--recommendations of the Israeli Allergy and Clinical Immunology Association].. PubMed. 152(9). 506–12, 565. 1 indexed citations
15.
Mahlab‐Guri, Keren, et al.. (2011). Inhaled Fluticasone Causes Iatrogenic Cushing’s Syndrome in Patients Treated with Ritonavir. Journal of Asthma. 48(8). 860–863. 26 indexed citations
16.
Elbirt, Daniel, et al.. (2010). The management of systemic lupus erythematosus: Facts and controversies. Clinics in Dermatology. 28(3). 330–336. 8 indexed citations
17.
Sthoeger, Zev, Amir Sharabi, Yair Molad, et al.. (2009). Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): Immunomodulation of gene expression. Journal of Autoimmunity. 33(1). 77–82. 44 indexed citations
18.
Zeilig, Gabriel, et al.. (2009). Risk factors for failure of heparin thromboprophylaxis in patients with acute traumatic spinal cord injury. Thrombosis Research. 125(6). 501–504. 8 indexed citations
19.
20.
Sthoeger, Zev, et al.. (2008). High α‐defensin levels in patients with systemic lupus erythematosus. Immunology. 127(1). 116–122. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriel Cohen Breakdown of academic impact, for papers by Emõke Endreffy Breakdown of academic impact, for papers by E Livni Breakdown of academic impact, for papers by Ori Elkayam Breakdown of academic impact, for papers by Neil Kramer Breakdown of academic impact, for papers by Stella Bowcock Breakdown of academic impact, for papers by J. Keith Pinckard Breakdown of academic impact, for papers by B. Ramsay Breakdown of academic impact, for papers by Paul J. Newcombe Breakdown of academic impact, for papers by L Hill
Rankless by CCL
2026